Suchergebnisse - "Taub, Jeffrey W"

PubPharm (54)

1

Co-targeting of HDAC, PI3K, and Bcl-2 results in metabolic and transcriptional reprogramming and decreased mitochondrial function in acute myeloid leukemia

enthalten in: Biochemical pharmacology | 2022

von Hege Hurrish, K. | Qiao, X. | Li, X. | +13

2

Meditation reduces brain activity in the default mode network in children with active cancer and survivors

enthalten in: Pediatric blood & cancer | 2022

von Hehr, A. | Iadipaolo, A. | Morales, A. | +7

3

Slow Transcription of the 99a/let-7c/125b-2 Cluster Results in Differential MiRNA Expression and Promotes Melanoma Phenotypic Plasticity

enthalten in: The Journal of investigative dermatology | 2021

von Sheinboim, D. | Parikh, S. | Parikh, R. | +15

4

The combination of CUDC-907 and gilteritinib shows promising in vitro and in vivo antileukemic activity against FLT3-ITD AML

enthalten in: Blood cancer journal | 2021

von Qiao, X. | Ma, J. | Knight, T. | +14

5

The HDAC and PI3K dual inhibitor CUDC-907 synergistically enhances the antileukemic activity of venetoclax in preclinical models of acute myeloid leukemia

enthalten in: Haematologica | 2021

von Li, X. | Su, Y. | Hege, K. | +15

6

Safety, pharmacokinetics, and pharmacodynamics of panobinostat in children, adolescents, and young adults with relapsed acute myeloid leukemia

enthalten in: Cancer | 2020

von Karol, S. | Cooper, T. | Mead, P. | +15

7

Pathologic Features of Down Syndrome Myelodysplastic Syndrome and Acute Myeloid Leukemia : A Report From the Children's Oncology Group Protocol AAML0431

enthalten in: Archives of pathology & laboratory medicine | 2020

von Mast, K. | Taub, J. | Alonzo, T. | +12

8

Inhibition of CDK9 by voruciclib synergistically enhances cell death induced by the Bcl-2 selective inhibitor venetoclax in preclinical models of acute myeloid leukemia

enthalten in: Signal transduction and targeted therapy | 2020

von Luedtke, D. | Su, Y. | Ma, J. | +10

9

Heritable variation at the chromosome 21 gene ERG is associated with acute lymphoblastic leukemia risk in children with and without Down syndrome

enthalten in: Leukemia | 2019

von de Smith, A. | Walsh, K. | Morimoto, L. | +29

10

Antileukemic activity and mechanism of action of the novel PI3K and histone deacetylase dual inhibitor CUDC-907 in acute myeloid leukemia

enthalten in: Haematologica | 2019

von Li, X. | Su, Y. | Madlambayan, G. | +13

1
2
3
4
5
6
Nächster »
[6]